Tag Archives: Light

Supporting the increased bandwidth demands of light rail with new antenna range from HUBER+SUHNER

Dedicated antennas optimised for light rail vehicles have been launched by HUBER+SUHNER, further expanding its offering to the transport sector. As all transportation market segments look to cope with rising bandwidth demand, rail, light rail, and road vehicles all have different requirements. The SENCITY® Tram rooftop antennas range has been developed to provide an all-in-one… Read More »

Essential Reads: Bright Light Therapy for the Treatment of Depression During Pregnancy, Mixed Findings

Despite data to support the reproductive safety of many antidepressants during pregnancy, many women would prefer to avoid medications, if possible.  In this setting, many women pursue psychotherapy, others use acupuncture or yoga or exercise. Although non-pharmacologic treatments are perceived as being safer than medications, this is only true if the treatment is effective.  Exposure… Read More »

Aduhelm and Alzheimer’s Disease: A Potential Medicare Budget-Buster Puts A Blazing Light on Health Care Costs and Innovation

The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s… Read More »

MGH-led study shows light therapy is safe

Light therapy is safe and has measurable effects in the brain, according to a pioneering study  by researchers from the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH). Senior investigators Rajiv Gupta, director of the Ultra-High Resolution Volume CT Lab at MGH, and Benjamin Vakoc at the Wellman Center led the study, which was… Read More »

Roche’s Tecentriq gets a green light to challenge Bayer with first-in-class liver cancer nod

After years of having the previously untreated liver cancer market all to itself, Bayer’s Nexavar is getting its first major competition—and it’s coming from Roche’s Tecentriq. The FDA Friday cleared a combination of the checkpoint inhibitor and fellow Roche med Avastin for previously untreated patients with hepatocellular carcinoma, the most common form of the disease.… Read More »